Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.69 | 21.48 |
| PEG Ratio (TTM) | 3.25 | 2.29 |
| P/S Ratio (TTM) | 0.94 | 2.00 |
| P/B Ratio (TTM) | 1.27 | 3.50 |
| P/FCF Ratio (TTM) | 269.55 | 31.16 |
| Price to 5YR AVG Earnings Ratio | 19.96 | -199.64 |
| Price to 5YR AVG FCF Ratio | 25.70 | -75.60 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.98% | 8.67% |
| ROE (TTM) | 7.34% | 14.05% |
| Net Profit Margin (TTM) | 5.33% | 8.32% |
| ROIC 5YR AVG | 4.96% | 12.57% |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 8.45% | -11.66% | 20.12% |
| Revenue | 2.99% | 27.06% | 23.15% |
| Net Income | 8.11% | -11.29% | 20.82% |
| Cash Flow | 266.19% | 84.50% | 172.02% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.06 | 3.18 |
| Quick Ratio (TTM) | 2.19 | 2.02 |
| D/E Ratio (TTM) | 0.26 | 0.57 |
| Interest Coverage (TTM) | 6.94 | 176.55 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 2.80 | 5.88 |
| LTL to 5YR AVG FCF | 3.15 | -31.18 |
| Shares Outstanding Growth 5YR AVG | 0.53% | -0.36% |